Skip to main content
Menu

Conditions Seborrheic Dermatitis

Seborrheic Dermatitis VA Rating

Written and reviewed by Landon · Updated October 6, 2026

Seborrheic dermatitis is generally evaluated under DC 7806 and the General Rating Formula for the Skin. The percentage turns on affected body or exposed area and systemic-treatment duration, not itch severity alone.

Board of Veterans' Appeals: 19.9% granted across 604 decided Board rulings on Seborrheic Dermatitis, 2021 to 2026. What this number means

Ask Raven about Seborrheic Dermatitis

Answers grounded in VA rules and Board decisions. Free to start.

How VA rates Seborrheic Dermatitis

DC 7806: Dermatitis / Eczema / Seborrheic Dermatitis

DC 7806 rating criteria and monthly pay
RatingWhat VA looks forMonthly pay (2026, veteran alone)Calculator
0%No more than topical therapy required over the past 12-month period and at least one of the following: characteristic lesions involving less than 5 percent of the entire body affected; or characteristic lesions involving less than 5 percent of exposed areas affected$0.00Not applicable
10%At least one of the following: characteristic lesions involving at least 5 percent, but less than 20 percent, of the entire body affected; or at least 5 percent, but less than 20 percent, of exposed areas affected; or intermittent systemic therapy including, but not limited to, corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, PUVA, or other immunosuppressive drugs required for a total duration of less than 6 weeks over the past 12-month period$180.42Try it
30%At least one of the following: characteristic lesions involving 20 to 40 percent of the entire body or 20 to 40 percent of exposed areas affected; or systemic therapy including, but not limited to, corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, PUVA, or other immunosuppressive drugs required for a total duration of 6 weeks or more, but not constantly, over the past 12-month period$552.47Try it
60%At least one of the following: characteristic lesions involving more than 40 percent of the entire body or more than 40 percent of exposed areas affected; or constant or near-constant systemic therapy including, but not limited to, corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, psoralen with long-wave ultraviolet-A light (PUVA), or other immunosuppressive drugs required over the past 12-month period$1,435.02Try it

Rated under the General Rating Formula for the Skin (38 CFR § 4.118). Systemic therapy is treatment administered through any route other than the skin (orally, injection, suppository, intranasally); topical therapy is administered through the skin (§ 4.118(a)). The formula also allows rating as disfigurement of the head, face, or neck (DC 7800) or scars (DCs 7801, 7802, 7804, or 7805), depending upon the predominant disability. DC 7806 is dermatitis or eczema.

Monthly pay is the basic amount for a veteran alone at that overall rating. Separate ratings combine under VA rules; the payments do not add together. Combine your ratings in the calculator or read the VA compensation rates (opens in a new tab).

Criteria checked against 38 CFR Part 4 (eCFR) as of 2026-07-01. 38 CFR § 4.118 explained (official text (opens in a new tab)).

VA forms for Seborrheic Dermatitis

A Disability Benefits Questionnaire (DBQ) is a VA form your clinician uses to document your condition and its effects.

Preparing a Seborrheic Dermatitis claim?

Check your evidence or draft your lay statement before you read the full Board breakdown.

On this page
  1. TL;DR
  2. Seborrheic dermatitis VA rating criteria (DC 7806)
  3. Topical versus systemic therapy for a VA skin rating
  4. The seborrheic dermatitis C&P exam
  5. Seborrheic dermatitis rated as disfigurement or scars
  6. How to prove seborrheic dermatitis is service connected
  7. Why VA denies seborrheic dermatitis claims
  8. Questions veterans ask about seborrheic dermatitis
    1. Is seborrheic dermatitis a VA disability?
    2. What is the highest VA rating for seborrheic dermatitis?
    3. Does a topical steroid count as systemic therapy for a VA skin rating?
    4. Can seborrheic dermatitis be secondary to PTSD?
    5. Can VA rate seborrheic dermatitis and another skin condition separately?
  9. Bottom Line

Seborrheic dermatitis commonly affects the scalp, the central face, including the folds beside the nose, and the upper chest. For VA purposes, it is generally evaluated as dermatitis or eczema under Diagnostic Code 7806 in 38 CFR § 4.118.

The General Rating Formula for the Skin offers two main paths: how much of the entire body or exposed areas the characteristic lesions cover, and how long qualifying systemic therapy was required during the prior 12 months. Because the face counts as an exposed area, a relatively small total-body footprint can still matter. If disfigurement or scars are the predominant disability, the schedule permits a different rating path.

The biggest evidence problem is timing. Seborrheic dermatitis is a chronic condition that flares and improves. A clear exam day can understate the condition unless the record preserves photographs, treatment history, and clinician estimates from active periods.

This page covers the seborrheic dermatitis rating criteria, topical versus systemic therapy, the C&P exam, rating as disfigurement or scars, how to prove service connection, and why VA denies these claims.


TL;DR

  • Seborrheic dermatitis is generally rated under DC 7806 and the General Rating Formula for the Skin.
  • 0%: less than 5 percent of the body and exposed areas, with no more than topical therapy during the past 12 months.
  • 10%: 5 to less than 20 percent of the body or exposed areas, or systemic therapy for less than six weeks during the prior 12 months.
  • 30%: 20 to 40 percent of the body or exposed areas, or systemic therapy for six weeks or more but not constantly.
  • 60%: more than 40 percent of the body or exposed areas, or constant or near-constant systemic therapy.
  • Under § 4.118(a), systemic therapy is treatment administered by a route other than the skin. Topical therapy is treatment administered through the skin.
  • The schedule also permits evaluation as disfigurement of the head, face, or neck or as scars when that is the predominant disability.
  • Stress has been linked to flares, but it does not create an automatic secondary link to PTSD or anxiety.
  • Across 604 decided Board rulings on seborrheic dermatitis from 2021 to 2026, 19.9% were granted, 33.4% denied and 46.7% remanded. The Board section below breaks those rulings down.

Seborrheic dermatitis VA rating criteria (DC 7806)

The current skin formula provides these levels.

  • 0%: characteristic lesions involving less than 5 percent of the entire body and less than 5 percent of exposed areas, with no more than topical therapy required during the past 12 months.
  • 10%: lesions involving at least 5 but less than 20 percent of the entire body or exposed areas, or intermittent systemic therapy for a total duration of less than six weeks during the prior 12 months.
  • 30%: lesions involving 20 to 40 percent of the entire body or exposed areas, or systemic therapy for six weeks or more but not constantly during the prior 12 months.
  • 60%: lesions involving more than 40 percent of the entire body or exposed areas, or constant or near-constant systemic therapy during the prior 12 months.

The body-area and treatment paths are alternatives. A veteran can meet a level through either. The regulation lists the two 0 percent area measures with "or," but reaching 5 percent on either measure already meets the 10 percent level, so in practice 0 percent means both measures stay under 5 percent and treatment was topical only. The percentage is not based on itch, flakes, embarrassment, or treatment difficulty by themselves, though those facts can explain functional impact and flare history.

Topical versus systemic therapy for a VA skin rating

Section 4.118(a) defines the distinction by route.

  • Systemic therapy is administered by a route other than the skin, such as orally, by injection, suppository, or intranasally.
  • Topical therapy is administered through the skin.

That current definition prevents a common error: assuming a topical corticosteroid is systemic merely because corticosteroids can be systemic drugs in other forms. In Johnson v. Shulkin, 862 F.3d 1351 (Fed. Cir. 2017), the Federal Circuit rejected the reading that any use of a topical corticosteroid is systemic therapy under DC 7806, and VA wrote the route definition into the skin rules effective August 13, 2018. The treatment record should identify the medication, route, start and stop dates, frequency, and the skin condition it treated.

The formula lists examples such as corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, PUVA, and other immunosuppressive drugs, but the route and duration still need to match the current rule.

Standard treatment for seborrheic dermatitis relies mainly on antifungals, topical corticosteroids and calcineurin inhibitors. Applied to the skin, including as a medicated shampoo, those are topical therapy for VA purposes. Oral isotretinoin, a retinoid that has been studied for moderate to severe seborrheic dermatitis, is systemic therapy by route.

The seborrheic dermatitis C&P exam

The C&P examiner should estimate both the entire-body percentage and the exposed-area percentage. VA's Skin Diseases Disability Benefits Questionnaire (DBQ) asks for the exposed area as the face, neck and hands. Because exposed area is an independent route, facial involvement should not disappear inside a small total-body number. Scalp involvement counts toward the entire-body figure; the scalp is not on the form's list of exposed areas.

The examiner should document these points.

  • every affected location;
  • percentage of the entire body and exposed areas;
  • lesion appearance and any disfigurement or scar features;
  • all treatments during the prior 12 months, including route and total duration;
  • flare frequency, duration, triggers, and severity;
  • whether the exam occurs during an active phase; and
  • work or daily-function effects.

If the condition is inactive that day, ask that the report acknowledge the history and the submitted flare evidence. Photographs and contemporaneous dermatology records can bridge the snapshot gap. Useful evidence from a flare includes the following.

  • dated photographs from consistent angles and lighting;
  • dermatology notes describing each affected region;
  • clinician estimates of total and exposed area;
  • records of scaling, redness, crusting, or inflammation;
  • prescription and refill history; and
  • a calendar showing flare duration and treatment.

Veterans can describe locations and duration, but a clinician's percentage estimate is stronger than a self-calculated body-surface number. The C&P exam prep tool can help you organize that history before the exam.

Seborrheic dermatitis rated as disfigurement or scars

The General Rating Formula permits evaluation under DC 7800 for disfigurement of the head, face, or neck, or under the scar codes, depending on the predominant disability. This is an alternative evaluation path, not permission to count the same lesion effects twice.

When persistent facial changes, tissue characteristics, painful scarring, or unstable scars are present, the examination should document those features. See the scars page for the separate criteria. 38 CFR § 4.14 still prohibits duplicating the same manifestation under multiple codes.

How to prove seborrheic dermatitis is service connected

Direct service connection. In-service treatment, photographs, shaving profiles, medical visits for scalp or facial symptoms, and credible statements can establish onset. A current diagnosis and a medical link to that history complete the path under § 3.303.

Continuity evidence. Because the condition waxes and wanes, gaps in formal treatment do not necessarily mean symptoms stopped. Statements, photos, over-the-counter purchase records, and primary-care notes can help document the course, while the medical nexus addresses whether it is the same chronic condition.

Secondary aggravation. Stress is a recognized flare factor: in a 2020 study of patients seen by a dermatologist, a higher level of stress in the past month was linked to flares. That does not prove PTSD or anxiety caused the skin disease. A claim under 38 CFR § 3.310(b) needs a clinician's opinion that your seborrheic dermatitis is aggravated by your service-connected condition, meaning it would be less severe but for that condition, plus medical evidence of baseline severity and of the measurable worsening attributable to the service-connected condition.

Why VA denies seborrheic dermatitis claims

Seborrheic dermatitis claims do a little worse at the Board than the average claim. Across 604 decided Board rulings on seborrheic dermatitis from 2021 to 2026, 19.9% were granted, 33.4% denied and 46.7% remanded. That grant rate is 4.8 points below the Board-wide 24.7 percent.

When the Board denied service connection for seborrheic dermatitis, the missing piece was the medical link to service, not the diagnosis or the in-service history. The rating side has its own failure points. These patterns repeat.

No medical link to service. The service records show scalp or facial treatment, but no opinion explains why the current seborrheic dermatitis is the same condition rather than a later onset.

Only the scalp is counted. Facial, chest, or other involved areas never make it into the DBQ.

Exposed area is omitted. The examiner reports total body percentage but not the separate exposed-area percentage.

Topical treatment is called systemic. The route definition in § 4.118(a) is ignored.

Treatment duration is vague. The record lists medications but not how many weeks they were used during the relevant 12 months.

A clear-day exam controls. The file contains no dated flare photographs or active-phase treatment notes.

Stress is treated as an automatic link. The medical evidence does not establish causation or aggravation by a service-connected condition. On the other side, a VA opinion that says only "not caused by" and never addresses whether the service-connected condition made the skin disease worse is inadequate (El-Amin v. Shinseki, 26 Vet. App. 136 (2013)).

When the Board sends a seborrheic dermatitis claim back instead of deciding it, the most common reason is an inadequate VA exam or opinion, followed by records VA still had to get. The Board section below shows the remand reasons, results by what the appeal asked for, and how claims argued as direct, secondary and presumptive have fared.

Questions veterans ask about seborrheic dermatitis

Is seborrheic dermatitis a VA disability?

Yes, when it is service connected. VA rates it under DC 7806, dermatitis or eczema, with the General Rating Formula for the Skin, from 0 to 60 percent. You need a current diagnosis, evidence of onset or treatment in service, and a medical link between the two.

What is the highest VA rating for seborrheic dermatitis?

60 percent under the skin formula, for lesions on more than 40 percent of the entire body or exposed areas, or constant or near-constant systemic therapy over the past 12 months. If disfigurement of the head, face or neck is the predominant disability, VA can rate it under DC 7800 instead, which goes up to 80 percent.

Does a topical steroid count as systemic therapy for a VA skin rating?

No. Under 38 CFR § 4.118(a), treatment applied through the skin is topical therapy, including a steroid cream, lotion or medicated shampoo. Only treatment given by another route, such as by mouth or by injection, counts toward the systemic-therapy levels.

Can seborrheic dermatitis be secondary to PTSD?

It can, but only with a medical opinion about your case. Because stress is a recognized flare factor, the usual theory is aggravation: that your service-connected PTSD made the skin disease worse than it would otherwise be. Under § 3.310(b), VA also needs medical evidence of how severe the skin disease was before that worsening.

Can VA rate seborrheic dermatitis and another skin condition separately?

Only when they involve separate areas of skin. Under 38 CFR § 4.118(b), if two skin conditions affect the same area, VA uses only the highest evaluation. Seborrheic dermatitis on the face and eczema on the legs can be rated separately and combined; two conditions on the same patch of scalp cannot.

Bottom Line

Seborrheic dermatitis is generally a DC 7806 claim. The rating depends on the higher qualifying path between body or exposed-area coverage and systemic-treatment duration. Preserve active-flare evidence, document every treated area, distinguish topical from systemic therapy by route, and consider the disfigurement or scar formula only when that is the predominant disability.

Methodology and Limitations

  • Authorities checked: 38 CFR §§ 3.303, 3.310, 4.14, and 4.118, including § 4.118(a) and (b), the General Rating Formula for the Skin, DC 7800, and DC 7806, checked on October 6, 2026 against the eCFR text current on October 1, 2026. The topical and systemic distinction was also checked against VA's 2018 skin rule (83 FR 32592, effective August 13, 2018), which discusses Johnson v. Shulkin. The exposed-area definition comes from VA's Skin Diseases DBQ (updated July 15, 2024).
  • Medical sources: Navarro Triviño et al., "Seborrheic Dermatitis Revisited," Biomedicines (2025); Schwartz et al., "Seborrheic dermatitis: an overview," American Family Physician (2006); Lancar et al., "Risk Factors for Seborrhoeic Dermatitis Flares," Acta Dermato-Venereologica (2020); and Alsayoud et al., a systematic review of isotretinoin for seborrheic dermatitis, Clinical, Cosmetic and Investigational Dermatology (2025), each read as a PubMed abstract. Treatment decisions belong to a clinician.
  • Board statistics: Claim Raven's read of 510,968 Board decisions from 2021 to 2026, which contain 1,376,193 rulings. Of 658 Board rulings on seborrheic dermatitis, 604 were decided; dismissed, withdrawn and moot rulings are excluded from the shares, and the Board section below is computed from the same data.
  • Limitations: Body-area estimates and treatment classification depend on the medical record. This page explains the schedule and does not estimate an individual percentage.

What Board appeals show for Seborrheic Dermatitis

These are outcomes at the Board of Veterans' Appeals, not first-time claims, and not your personal odds. They show where appeals on this issue tend to land.

How appeals on this issue ended

19.9%

granted across 604 decided Board rulings on Seborrheic Dermatitis, 2021 to 2026.

  • Granted120 19.9%
  • Denied202 33.4%
  • Sent back282 46.7%

"Sent back" means remanded: the Board returned the claim to VA for more work instead of deciding it.

When the Board discussed testimony at a Board hearing

Rulings where the Board's decision discussed testimony at a Board hearing (214)23.4%

All Seborrheic Dermatitis rulings (604)19.9%

Association, not cause; the Board may simply discuss stronger evidence more.

The full evidence breakdown, with grant rates for every evidence type and language from actual Board decisions, is in Claim Raven's VA data, included with every paid plan.

Why the Board sent seborrheic dermatitis claims back

Of 282 seborrheic dermatitis rulings the Board remanded, 2021 to 2026:

  • The VA exam or opinion was not adequate64.2%
  • VA still had records to get34.4%
  • VA had not given an exam12.4%
  • The exam was out of date or the condition had worsened8.9%

A remand can ask for records and a new exam at once, so these overlap.

Results by what the appeal asked for

Board rulings on seborrheic dermatitis, 2021 to 2026, by the question the Board decided. The share is granted out of every decided ruling, remands included.

  • Service connection19.8% of 313
  • A higher rating16.5% of 254

Direct, secondary and presumptive claims

Service connection rulings on seborrheic dermatitis, 2021 to 2026, by how the claim was argued. The share is granted out of every decided ruling, remands included.

  • Direct: it began in service21.1% of 256
  • Presumptive: the law presumes the link12.8% of 133

All seborrheic dermatitis service connection rulings: 19.8% of 313.

A presumptive claim is also counted as direct or secondary.

How seborrheic dermatitis appeals have gone since 1992

Every Board ruling on seborrheic dermatitis since 1992, by when it was decided. The share is granted out of every decided ruling.

  • 1992 to 20029.5% of 347
  • 2003 to February 201914.2% of 887
  • February 2019 to August 2022 (new appeals system)12.5% of 448
  • Since August 2022 (PACT Act)21.8% of 527

These rows come from a simpler reading of every decision's order since 1992, so they are a different measure from the 2021 to 2026 figures elsewhere on this page. Issues with unclear outcomes, or with both a decision and a remand, are left out.

Do you need a nexus letter for Seborrheic Dermatitis?

A nexus opinion may matter when VA disputes whether this condition is connected to service or to an already service-connected condition.

  • If service connection is already established, the dispute may be about rating severity rather than nexus.
  • If a presumptive rule covers the condition and service, a separate nexus opinion may not be required.
  • If the current diagnosis, event, or medical explanation is missing, locate that evidence before asking a clinician for an opinion.

Do you need a nexus letter for this condition? Use the nexus letter builder.

Your next step

Get one VA document reviewed free

Upload a decision letter, medical record, exam report or statement. You get findings, source references and suggested next steps.

One free review per verified email. No credit card needed.

Write your personal statement

Describe your symptoms and daily impact, then download your statement. No account required.

Open the free builder

Ask Raven about Seborrheic Dermatitis

Ask specific questions about your seborrheic dermatitis claim and get answers grounded in Board decisions.

Ask a question

Have a VA decision letter? Ask Raven explains it in plain English. Have your VA medical records? A medical records review looks for conditions you have not claimed.

Grant rates reflect Board outcomes on appealed claims, not initial-claim outcomes. Claim Raven is not legal or medical advice and is not affiliated with the VA.

Veterans Crisis Line: dial 988, then press 1